Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000231

EVP CLO & General Counsel sold 21,000 shares at $64.56 ($1,355,661)

  • EVP CLO & General Counsel acquired 21,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
O'NEIL PATRICK R. EVP CLO & General Counsel 2025-09-09 Option exercise 10b5-1 +20,000 $60.89 $1,217,800 77,130 D: show line 1 in the form
O'NEIL PATRICK R. EVP CLO & General Counsel 2025-09-09 Sale 10b5-1 −20,000 $64.56 $1,291,106 57,130 D: show line 2 in the form
O'NEIL PATRICK R. EVP CLO & General Counsel 2025-09-09 Option exercise 10b5-1 +1,000 $56.78 $56,780 58,130 D: show line 3 in the form
O'NEIL PATRICK R. EVP CLO & General Counsel 2025-09-09 Sale 10b5-1 −1,000 $64.56 $64,555 57,130 D: show line 4 in the form
Open-market sales · 21,000 sh · avg $64.56 · $1,355,661

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
O'NEIL PATRICK R. EVP CLO & General Counsel 2025-09-09 Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 −1,000 57,203 D: show line 5 in the form
O'NEIL PATRICK R. EVP CLO & General Counsel 2025-09-09 Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 −20,000 34,461 D: show line 6 in the form
Loading xslF345X05/edgardoc.xml…